Intestinal lesions of streptozotocin-induced diabetes and the effects of Azadirachta indica treatment

Pharmacologyonline

Volumn 3, Issue , 2009, Pages 872-881

  Akinola, Oluwole B ^a   Zatta, Laura ^b   Dosumu, Olufunke O ^c   Akinola, Oluwafunmike S ^a   Adelaja, Akinlolu A ^a   Dini, Luciana ^b   Caxton Martins, Ezekiel A ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

^b UNIVERSITY OF SALENTO   (Italy)

^c UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Azadirachta indica; Intestinal lesions; Streptozotocin diabetes

Indexed keywords

AZADIRACHTA INDICA EXTRACT; GLIBENCLAMIDE; GLUCOSE; HYPERGLYCEMIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL STRUCTURE; DISEASE ASSOCIATION; DISEASE MODEL; DRUG EFFECT; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GOBLET CELL; HISTOPATHOLOGY; ILEUM MUCOSA; INTESTINE INJURY; MALE; NONHUMAN; PLANT LEAF; PROPHYLAXIS; RAT; STREPTOZOCIN DIABETES;

EID: 77649248005     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schein PS, Cooney DA, Vernon ML. The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. Cancer Res. 1967; 27:2324-2332.
2. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 1963; 29:91-98.
3. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 2001; 50: 536-546
4. Weiss RB. Streptozotocin: a review of its pharmacology, efficacy and toxicity. Cancer Treat. Rep. 1982; 66: 427-438.
5. Chattopadhyay RR. Possible mechanism of antihyperglycaemic effect of Azadirachta indica leaf extract. Part V. J. Ethnopharmacol. 1999; 67: 373-376.
6. Lal MA, Korner A, Matsuo Y, et al. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 2000; 49: 1381-1389.
7. Lenzen S. The mechanism of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008; 51: 216-226.
8. Gupta S, Kataria M, Gupta PK, Murganandan S, Yashroy RC. Protective role of extract of neem seeds in diabetes caused by streptozotocin in rats. J. Ethnopharmacol. 2004; 90: 185-189.
9. Sathishsekar D, Subramanian S. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol Pharm Bull 2005; 28: 978-983.
10. Murty SK, Narayana RD, Krishna RD, Gopalakrishna ML. A preliminary study on hypoglycaemic and antihyperglycaemic effect of Azadirachta indica. Indian J. Pharmacol. 1978; 10: 247-250.
11. Ebong PE, Atangwho IJ, Eyong, Egbung GE. The Antidiabetic Efficacy of Combined Extracts from Two Continental Plants: Azadirachta indica (A. Juss) (Neem) and Vernonia amygdalina (Del.) (African Bitter Leaf). Am. J. Biochem. Biotechnol. 2008; 4: 239-244.
12. Khosla P, Bhanwra S, Singh J, Seth S, Srivastava RK. A study of hypoglycaemic effects of Azadirachta indica (neem) in normaland and alloxan diabetic rabbits. Indian J Physiol. Pharmacol 2000; 44: 69-74.
13. Chattopadhyay RR. Possible mechanism of antihyperglycaemic effect of Azadirachta indica leaf extract. Part IV. Gen. Pharmac. 1996; 27: 431-434.
14. Szayna M, Doyle ME, Betkey JA, et al. Exendin-4 decelerates food intake, weight gain and fat deposition in Zucker rats. Endocrinol. 2000; 141: 1936-1941.
15. Siddiqui BS, Afshan F, Gulzar T, Hanif M. Tetracyclic triterpenoids from the leaves of Azadirachta indica. Phytochemistry 2004; 65: 2363-2367.
16. Adewole SO, Ojewole JA, Caxton-Martins EA. Protective effects of quercetin on the morphology of pancreatic β cells of streptozotocin-treated diabetic rats. Afr. J Compl. Alternative Med. 2007; 4: 64-74.
17. Srinivasan K, Kaul CL, Ramarao P. Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice. Indian J Pharmacol 2005; 37: 327-328.
18. Sanders RA, Rauscher FM, Watkins III JB. Effect of quercetin on antioxidant defence in STZ-induced diabetic rats. J Biochem Mol Toxicol 2001; 15: 143-149.
19. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego M. Quercetin decreases oxidative stress, NFkB activation and iNOS overexpression in liver of STZ-induced diabetic rats. J. Nutr. 2005; 135: 2299-2304.
20. Bjelakovic G, Nagorni A, Stamenkovic I et al. Diabetes mellitus and digestive disorders. Acta Fac. Med. NAISS 2005; 22: 43-50.
21. De La Casas LE, Finley JL. Diabetic microangiopathy in the small bowel. Histopathology 1999; 35: 267-270.
22. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and Autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem J 1988; 256: 205-212
23. th edition, Singapore. 2007; pg 687.
24. Bhattacharjee M, Bhattacharjee S, Gupta A et al. Critical role of an endogenous gastric peroxidase in controlling oxidative damage in H. pylori-mediated and non-mediated gastric ulcer. Free Radic. Biol. Med. 2002; 32: 731-743.
25. Biswas K, Bandyopadhyay U, Chattopadhyay I et al. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J. Biol. Chem. 2003; 278: 10993-11001.
26. Bandyopadhyay U, Biswas K, Sengupta A et al. Clinical studies on the effect of neem (Azadirachta indica) bark extract on gastric secretion and gastroduodenal ulcer. Life Sci. 2004; 75: 2867-2878.
27. +-ATPase, oxidative damage and apoptosis. Inflammopharmacol. 2004; 12: 153-176.
28. Ofusori DA, Falana BA, Adelakun AE, Caxton-martins EA. Gastroprotective effect of aqueous extract of neem Azadirachta indica on induced lesions in rats. Internet J. Gatroenterol. 2008; 7: 1-7.
29. Garg GP, Nigam SK, Ogle CW. The anti-gastric effects of the leaves of neem tree. Planta Med 1993; 59: 215-217.